These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19813338)

  • 1. [Influence of ACE inhibitors and fibrates on endothelial function].
    Januszewicz A
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II60-4. PubMed ID: 19813338
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pleiotropic action of ACE-I and fibrates].
    Okopień B; Haberka M; Sierant M
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II65-8. PubMed ID: 19813339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug prevention and preventive management of age related macular degeneration by positive modification of vascular endothelial dysfunction].
    Fischer T
    Klin Monbl Augenheilkd; 2004 Dec; 221(12):1062. PubMed ID: 15599815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paralipomena as a reason for publication].
    Fischer T
    Klin Monbl Augenheilkd; 2006 Feb; 223(2):178-9. PubMed ID: 16485234
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrate therapy: safety considerations.
    Usman M; Peter R
    Curr Opin Lipidol; 2007 Dec; 18(6):702-4. PubMed ID: 17993818
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 11. ACE inhibitors, diabetes and cardiovascular disease.
    Gazis A; Page SR; Cockcroft JR
    Diabetologia; 1998 May; 41(5):595-7. PubMed ID: 9628279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of endothelial dysfunction with ACE inhibitors].
    Internist (Berl); 1997 Mar; 38(3 Suppl Therapie D):1-8. PubMed ID: 9541668
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors and endothelial dysfunction.
    Carretaro OA
    Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843
    [No Abstract]   [Full Text] [Related]  

  • 14. [Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
    MMW Fortschr Med; 2000 Jan; 142(1-2):54-5. PubMed ID: 11291163
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular benefit of cholesterol-lowering therapy: does improved endothelial vasodilator function matter?
    Cannon RO
    Circulation; 2000 Aug; 102(8):820-2. PubMed ID: 10952945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 17. Key developments in cardiovascular medicine.
    Appleby MA; Hall A
    Practitioner; 2002 Jun; 246(1635):375-7, 380-2. PubMed ID: 12073696
    [No Abstract]   [Full Text] [Related]  

  • 18. [New perspectives for patients at risk for atherosclerosis. The importance of ACE inhibitors in cardiovascular prevention].
    Landgraf W; Klein HH
    Pharm Unserer Zeit; 2003; 32(1):36-44. PubMed ID: 12577759
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
    Barter PJ; Rye KA
    Circulation; 2006 Mar; 113(12):1553-5. PubMed ID: 16567579
    [No Abstract]   [Full Text] [Related]  

  • 20. [No advantage of the combination of ACE-inhibition and angiotensin receptor blockade in patients with high cardiovascular risk].
    Slagman MC; Waanders F; Navis GJ
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2150-1; author reply 2151. PubMed ID: 18924267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.